Skip to content.

Spotlight

Ophelos team

Why we invested in Ophelos?

Read the article >
What do Founders worry about?

Reflections on CogX Founder Roundtable

Read the article >

A computing impasse – the investments we make now will define our future

Read the article >
What to expect in 2022

Tech trends in 2022

Read the article >

Why we invested in Brytlyt?

Read the article >
What's happening in biotech?

On not downclimbing – the prospects for early stage biotech remain bright

Read the article >

Why we invested in Carbon Re?

Read the article >
Oviva story

Our journey with Oviva: seed to Series C

Read the article >

Bringing immuno-oncology cell therapies to the masses – are we (nearly) there yet?

Read the article >

Why we invested in Gravitee.io?

Read the article >
Will the boom last?

A window to the past: is the investment boom in biotech going to last?

Read the article >